Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance

International Journal of Obesity volume 29, pages 1321–1328 (2005)Cite this article

Abstract

OBJECTIVES:

The present study was undertaken to assess the differential impact of insulin resistance, leptin and body composition on myocardial mass and serum markers of cardiac fibrosis in obese subjects, within a small range of elevated BMI (30–40 kg/m2), without pulmonary disease, cardiovascular disease, hypertension, cardiac hypertrophy or other cardiovascular disease.

BACKGROUND:

Obesity is an independent predictor of left ventricular mass (LVM) and is associated with disturbances in cardiac structure. The extent of the interstitial fibrosis in obese patients is not known, especially in the absence of cardiac hypertrophy.

METHODS AND RESULTS:

We included 160 obese subjects. The LVM was obtained using the Devereux formula. Body composition was estimated from a total body scan. Insulin sensitivity was assessed by homeostasis model assessment (HOMA), and cardiac collagen turnover by measurement of procollagen type III aminopeptide (PIIINP). PIIINP was correlated to the E/A ratio (r=0.24; P=0.012), a marker of ventricular function. PIIINP was independently correlated with glucose concentration (r=0.27; P=0.004), indexes of insulin resistance (HOMA (r=0.27; P=0.003), insulin (r=0.24; P=0.008)), and parameters associated with the insulin-resistance syndrome (HDL-cholesterol r=−0.27; P=0.004) and fat trunk/fat leg ratio (r=0.24; P=0.053)). The variable most correlated with PIIINP was HDL-cholesterol, followed by HOMA (r2=0.13). When HOMA was substituted for blood glucose concentration and insulinemia (Model 2), HDL-cholesterol was strongly related to lower PIIINP levels, followed by higher glucose concentration (r2=0.21). Regression analyses showed that LVM had the strongest independent positive correlation with fat-free mass (FFM) (r=0.39; P=0.0002), followed by systolic blood pressure (r=0.19; P=0.034). Neither adipose mass nor height independently added information to multivariate models. The ratio leptin/fat mass was correlated with LVM (r=−0.27; P=0.004), but not independently of the FFM. Markers for fibrosis were not significantly correlated with LVM. As a result, FFM was the most predictive factor of LVM in obese subjects.

CONCLUSION:

We found that serum levels of markers of cardiac collagen synthesis were significantly associated with insulin resistance in normotensive, nondiabetic obese subjects, and not related to the LVM. As a result, PIIINP could be a very early marker of ventricular dysfunction in these patients. Furthermore, we suggest that, for better detection of left ventricle hypertrophy in obese subjects, LVM should be indexed to FFM rather than to body surface area, or height.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Lauer MS, Anderson KM, Kannel WB, Levy D . The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 266: 231–236.

    Article  CAS  Google Scholar 

  2. Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski G, Dunn FG, Frohlich E . Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 1983; 74: 808–812.

    Article  CAS  PubMed  Google Scholar 

  3. Alexander JK . Gross obesity; the cardiovascular consequences. Minn Med 1969; 52: 1289–1291.

    CAS  PubMed  Google Scholar 

  4. Alexander JK . Chronic heart disease due to obesity. J Chronic Dis 1965; 18: 895–898.

    Article  CAS  PubMed  Google Scholar 

  5. Bornfeldt KE, Skottner A, Arnqvist HJ . In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle. J Endocrinol 1992; 135: 203–211.

    Article  CAS  PubMed  Google Scholar 

  6. Geffner ME, Golde DW . Selective insulin action on skin, ovary and heart in insulin-resistant states. Diabetes Care 1988; 11: 500–505.

    Article  CAS  PubMed  Google Scholar 

  7. Galvan AQ, Galetta F, Natali A, Muscelli E, Sironi AM, Cini G, Camastra S, Ferrannini E . Insulin resistance and hyperinsulinemia: no independent relation to left ventricular mass in humans. Circulation 2000; 102: 2233–2238.

    Article  CAS  PubMed  Google Scholar 

  8. Natarajan R, Gonzales N, Xu L, Nadler JL . Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 1992; 187: 552–560.

    Article  CAS  PubMed  Google Scholar 

  9. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM . Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003; 108: 754–759.

    Article  CAS  PubMed  Google Scholar 

  10. Stephens TW, Caro JF . To be lean or not to be lean. Is leptin the answer? Exp Clin Endocrinol Diabetes 1998; 106: 1–15.

    Article  CAS  PubMed  Google Scholar 

  11. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H . Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000; 101: 899–907.

    Article  CAS  PubMed  Google Scholar 

  12. Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I . Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 1993; 46: 32–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Swynghedauw B . Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79: 215–262.

    Article  CAS  PubMed  Google Scholar 

  14. Weber KT . Monitoring tissue repair and fibrosis from a distance. Circulation 1997; 96: 2488–2492.

    Article  CAS  PubMed  Google Scholar 

  15. Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, Diez J . Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98: 535–540.

    Article  CAS  PubMed  Google Scholar 

  16. Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Martinez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP, Diez J . Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000; 101: 1729–1735.

    Article  CAS  PubMed  Google Scholar 

  17. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I . Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450–1456.

    Article  CAS  PubMed  Google Scholar 

  18. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler HG . Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 1995; 75: 913–918.

    Article  CAS  PubMed  Google Scholar 

  19. Host NB, Jensen LT, Bendixen PM, Jensen SE, Koldkjaer OG, Simonsen EE . The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction. Am J Cardiol 1995; 76: 869–873.

    Article  CAS  PubMed  Google Scholar 

  20. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y . Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 1997; 78: 505–508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C . Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871–878.

    Article  CAS  PubMed  Google Scholar 

  22. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.

    Article  CAS  PubMed  Google Scholar 

  23. Devereux RB, Liebson PR, Horan MJ . Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987; 9: II97–II104.

    CAS  PubMed  Google Scholar 

  24. Schiller NB . Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84: I280–I287.

    CAS  PubMed  Google Scholar 

  25. Devereux RB, Reichek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.

    Article  CAS  Google Scholar 

  26. Lauer MS, Anderson KM, Larson MG, Levy D . A new method for indexing left ventricular mass for differences in body size. Am J Cardiol 1994; 74: 487–491.

    Article  CAS  PubMed  Google Scholar 

  27. Krotkiewski M, Landin K, Mellstrom D, Tolli J . Loss of total body potassium during rapid weight loss does not depend on the decrease of potassium concentration in muscles—different methods to evaluate body composition during a low energy diet. Int J Obes Relat Metab Disord 2000; 24: 101–107.

    Article  CAS  PubMed  Google Scholar 

  28. He M, Tan KC, Li ET, Kung AW . Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes Relat Metab Disord 2001; 25: 748–752.

    Article  CAS  Google Scholar 

  29. Risteli J, Niemi S, Trivedi P, Maentausta O, Mowat AP, Risteli L . Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–718.

    CAS  PubMed  Google Scholar 

  30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA . Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  Google Scholar 

  31. Friedewald WT, Levy RI, Frederickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  Google Scholar 

  32. Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross Jr J . Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 1996; 93: 2188–2196.

    Article  CAS  PubMed  Google Scholar 

  33. Anversa P, Kajstura J, Cheng W, Reiss K, Cigola E, Olivetti G . Insulin-like growth factor-1 and myocyte growth: the danger of a dogma part II. Induced myocardial growth: pathologic hypertrophy. Cardiovasc Res 1996; 32: 484–495.

    CAS  PubMed  Google Scholar 

  34. Regan TJ, Wu CF, Yeh CK, Oldewurtel HA, Haider B . Myocardial composition and function in diabetes. The effects of chronic insulin use. Circ Res 1981; 49: 1268–1277.

    Article  CAS  PubMed  Google Scholar 

  35. Jain A, Avendano G, Dharamsey S, Dasmahapatra A, Agarwal R, Reddi A, Regan T . Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with diabetic heart. Circulation 1996; 93: 1396–1402.

    Article  CAS  PubMed  Google Scholar 

  36. Galderisi M, Paolisso G, Tagliamonte MR, Alfieri A, Petrocelli A, de Divitiis M, Varricchio M, de Divitiis O . Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension? J Hypertens 1997; 15: 745–750.

    Article  CAS  PubMed  Google Scholar 

  37. Sowers JR, Epstein M, Frohlich ED . Diabetes, hypertension and cardiovascular disease: an update. Hypertension 2001; 37: 1053–1059.

    Article  CAS  PubMed  Google Scholar 

  38. Spector KS . Diabetic cardiomyopathy. Clin Cardiol 1998; 21: 885–887.

    Article  CAS  PubMed  Google Scholar 

  39. Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, Tsuji T, Kohzuki H, Suga H, Taniguchi S, Takaki M . Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 2002; 282: H138–H148.

    Article  CAS  PubMed  Google Scholar 

  40. Zannad F, Alla F, Dousset B, Perez A, Pitt B . Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000; 102: 2700–2706.

    Article  CAS  PubMed  Google Scholar 

  41. Uusimaa P, Risteli J, Niemela M, Lumme J, Ikaheimo M, Jounela A, Peuhkurinen K . Collagen scar formation after acute myocardial infarction: relationships to infarct size left ventricular function and coronary artery patency. Circulation 1997; 96: 2565–2572.

    Article  CAS  PubMed  Google Scholar 

  42. Host NB, Aldershvile J, Horslev-Petersen K, Hoyer S, Haunso S . Serum aminoterminal propeptide of type III procollagen after cardiac transplantation and the effect of rejection. Am J Cardiol 1996; 78: 1406–1410.

    Article  CAS  PubMed  Google Scholar 

  43. Whittaker P, Boughner DR, Kloner RA . Analysis of healing after myocardial infarction using polarized light microscopy. Am J Pathol 1989; 134: 879–893.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Diez J, Laviades C . Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 1997; 35: 202–205.

    Article  CAS  PubMed  Google Scholar 

  45. Jensen LT, Horslev-Petersen K, Toft P, Bentsen KD, Grande P, Simonsen EE, Lorenzen I . Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation 1990; 81: 52–57.

    Article  CAS  PubMed  Google Scholar 

  46. Risteli J, Risteli L . Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995; 22: 77–81.

    Article  CAS  PubMed  Google Scholar 

  47. Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, Hashimi MW, Mukerji V . Relation of duration of morbid obesity to left ventricular mass, systolic function and diastolic filling and effect of weight loss. Am J Cardiol 1995; 76: 1194–1197.

    Article  CAS  PubMed  Google Scholar 

  48. Berkalp B, Cesur V, Corapcioglu D, Erol C, Baskal N . Obesity and left ventricular diastolic dysfunction. Int J Cardiol 1995; 52: 23–26.

    Article  CAS  PubMed  Google Scholar 

  49. Messerli FH, Aepfelbacher FC . Hypertension and left-ventricular hypertrophy. Cardiol Clin 1995; 13: 549–557.

    Article  CAS  PubMed  Google Scholar 

  50. Alpert MA, Lambert CR, Terry BE, Cohen MV, Mukerji V, Massey CV, Hashimi MW, Panayiotou H . Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J 1995; 130: 1068–1073.

    Article  CAS  Google Scholar 

  51. Vetta F, Cicconetti P, Ronzoni S, Rizzo V, Palleschi L, Canarile G, Lupattelli MR, Migliori M, Morelli S, Marigliano V . Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J 1998; 19: 326–331.

    Article  CAS  PubMed  Google Scholar 

  52. Avignon A, du Cailar G, Ribstein J, Monnier L, Mimran A . Determinants of the left ventricular mass in obese patients—influence of lean body mass. Arch Mal Coeur Vaiss 1997; 90: 1043–1046.

    CAS  PubMed  Google Scholar 

  53. Lind L, Berne C, Andren B, Lithell H . Relationship between diastolic hypertension and myocardial morphology and function in elderly males with diabetes mellitus. Diabetologia 1996; 39: 1603–1606.

    Article  CAS  PubMed  Google Scholar 

  54. Sasson Z, Rasooly Y, Bhesania T, Rasooly I . Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88: 1431–1436.

    Article  CAS  PubMed  Google Scholar 

  55. Sharp SD, Williams RR . Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology 1992; 81: 207–212.

    Article  CAS  PubMed  Google Scholar 

  56. Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA . Effect of lean body mass, fat mass, blood pressure and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological and clinical significance. Circulation 1995; 92: 3249–3254.

    Article  CAS  PubMed  Google Scholar 

  57. Bella JN, Devereux RB, Roman MJ, O'Grady MJ, Welty TK, Lee ET, Fabsitz RR, Howard BV . Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation 1998; 98: 2538–2544.

    Article  CAS  PubMed  Google Scholar 

  58. Panotopoulos G, Ruiz JC, Guy-Grand B, Basdevant A . Dual x-ray absorptiometry, bioelectrical impedance and near infrared interactance in obese women. Med Sci Sports Exerc 2001; 33: 665–670.

    Article  CAS  PubMed  Google Scholar 

  59. Jakicic JM, Wing RR, Lang W . Bioelectrical impedance analysis to assess body composition in obese adult women: the effect of ethnicity. Int J Obes Relat Metab Disord 1998; 22: 243–249.

    Article  CAS  PubMed  Google Scholar 

  60. Kuch B, Hense HW, Gneiting B, Doring A, Muscholl M, Brockel U, Schunkert H . Body composition and prevalence of left ventricular hypertrophy. Circulation 2000; 102: 405–410.

    Article  CAS  PubMed  Google Scholar 

  61. de Simone G, Devereux RB, Daniels SR, Mureddu G, Roman MJ, Kimball TR, Greco R, Witt S, Contaldo F . Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation 1997; 95: 1837–1843.

    Article  CAS  PubMed  Google Scholar 

  62. Jones EC, Devereux RB, O'Grady MJ, Schwartz JE, Liu JE, Pickering TG, Roman MJ . Relation of hemodynamic volume load to arterial and cardiac size. J Am Coll Cardiol 1997; 29: 1303–1310.

    Article  CAS  PubMed  Google Scholar 

  63. Kupari M, Koskinen P, Virolainen J . Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 1994; 89: 1041–1050.

    Article  CAS  PubMed  Google Scholar 

  64. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV . Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000; 101: 2271–2276.

    Article  CAS  PubMed  Google Scholar 

  65. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH . Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558.

    Article  CAS  PubMed  Google Scholar 

  66. Alpert MA, Lambert CR, Terry BE, Cohen MV, Mukerji V, Massey CV, Hashimi MW, Panayiotou H . Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients. Int J Obes Relat Metab Disord 1995; 19: 550–557.

    CAS  PubMed  Google Scholar 

  67. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D . Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension 1995; 25: 1155–1160.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Diabétologie, Maladies Métaboliques et de Nutrition, Hôpital Jeanne d'Arc, Centre Hospitalier Universitaire de Nancy, Nancy, France

    D Quilliot, P Böhme & O Ziegler

  2. Centre d'Investigation Clinique, INSERM-CHU, Centre Hospitalier Universitaire de Nancy, Nancy, France

    D Quilliot, F Alla, M Hammadi & F Zannad

  3. Service de Cardiologie, Centre Hospitalier Universitaire de Nancy, Hôpital central, Nancy, France

    J-F Bruntz

  4. Laboratoire de Chimie B, Centre Hospitalier Universitaire de Nancy, Hôpital central, Nancy, France

    B Dousset

Authors
  1. D Quilliot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Alla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Böhme
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J-F Bruntz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Hammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Dousset
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F Zannad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Quilliot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quilliot, D., Alla, F., Böhme, P. et al. Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. Int J Obes 29, 1321–1328 (2005). https://doi.org/10.1038/sj.ijo.0803022

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803022

Keywords

This article is cited by

Search

Advanced search

Quick links